ATE450535T1 - Neues verfahren zur herstellung von pleuromutilinderivaten - Google Patents

Neues verfahren zur herstellung von pleuromutilinderivaten

Info

Publication number
ATE450535T1
ATE450535T1 AT04782599T AT04782599T ATE450535T1 AT E450535 T1 ATE450535 T1 AT E450535T1 AT 04782599 T AT04782599 T AT 04782599T AT 04782599 T AT04782599 T AT 04782599T AT E450535 T1 ATE450535 T1 AT E450535T1
Authority
AT
Austria
Prior art keywords
new process
pleuromutilin derivatives
mutilin
ylsulfanyl
azabicyclo
Prior art date
Application number
AT04782599T
Other languages
English (en)
Inventor
Gary Breen
Michael Forth
Susan Kopelman
Francis Muller
Francis Sanderson
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Application granted granted Critical
Publication of ATE450535T1 publication Critical patent/ATE450535T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
    • C07D451/02—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
    • C07D451/04—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof with hetero atoms directly attached in position 3 of the 8-azabicyclo [3.2.1] octane or in position 7 of the 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
AT04782599T 2003-09-03 2004-08-30 Neues verfahren zur herstellung von pleuromutilinderivaten ATE450535T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US49978103P 2003-09-03 2003-09-03
PCT/US2004/028159 WO2005023257A1 (en) 2003-09-03 2004-08-30 Novel process, salts, compositions and use

Publications (1)

Publication Number Publication Date
ATE450535T1 true ATE450535T1 (de) 2009-12-15

Family

ID=34272868

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04782599T ATE450535T1 (de) 2003-09-03 2004-08-30 Neues verfahren zur herstellung von pleuromutilinderivaten

Country Status (7)

Country Link
US (2) US7875630B2 (de)
EP (2) EP1663220B1 (de)
JP (4) JP5460947B2 (de)
AT (1) ATE450535T1 (de)
DE (1) DE602004024417D1 (de)
ES (1) ES2335284T3 (de)
WO (1) WO2005023257A1 (de)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UY25225A1 (es) 1997-10-29 2000-12-29 Smithkline Beecham Plc Derivados de pleuromutilina utiles como agentes antimicrobianos
ES2335284T3 (es) * 2003-09-03 2010-03-24 Glaxo Group Limited Nuevo procedimiento para preparar derivados de pleuromutilina.
GB0504314D0 (en) * 2005-03-02 2005-04-06 Glaxo Group Ltd Novel polymorph
WO2006104667A2 (en) * 2005-03-10 2006-10-05 Smithkline Beecham Corporation Novel method
GB0513058D0 (en) * 2005-06-27 2005-08-03 Sandoz Ag Organic compounds
PL2101570T3 (pl) * 2006-12-14 2013-07-31 Teva Pharma Sól taninianu rasagiliny
MX2009006251A (es) * 2006-12-14 2009-10-12 Teva Pharma Base de rasagilina solida cristalina.
US8222407B2 (en) 2007-05-24 2012-07-17 Kyorin Pharmaceutical Co., Ltd. Mutilin derivative having heterocyclic aromatic ring carboxylic acid structure in substituent at 14-position
WO2009070307A1 (en) * 2007-11-26 2009-06-04 Teva Pharmaceutical Industries Ltd. Amorphous retapamulin and processes for preparation thereof
WO2009075776A1 (en) * 2007-12-05 2009-06-18 Teva Pharmaceutical Industries Ltd. Process for the preparation of retapamulin and its intermediates
WO2009095634A1 (en) * 2008-02-01 2009-08-06 Pliva Hrvatska D.O.O. Amorphous forms of retapamulin
US20100184987A1 (en) * 2008-11-13 2010-07-22 Teva Pharmaceutical Industries Ltd. Preparation of Retapamulin via its Pleuromutilin-thiol precursor
EP2399904A1 (de) 2010-05-26 2011-12-28 Nabriva Therapeutics AG Verfahren zur Herstellung von Pleuromutilinen
EP2624817A1 (de) * 2010-10-08 2013-08-14 Helperby Therapeutics Limited Neuartige zusammensetzung
CN102267992B (zh) * 2011-06-17 2012-10-31 华南农业大学 一种截短侧耳素类抗生素的制备方法
CN105198873B (zh) * 2014-06-11 2017-08-04 上海医药工业研究院 一种制备瑞他莫林的方法
TWI759267B (zh) 2015-07-02 2022-04-01 美商地平線罕見醫學製藥有限責任公司 Ａｄｏ抗性半胱胺類似物及其用途
TWI762573B (zh) 2017-02-10 2022-05-01 奧地利商納畢瓦治療有限責任公司 截短側耳素之純化
CN107324998B (zh) * 2017-07-31 2020-07-14 重庆华邦胜凯制药有限公司 一种制备外用抗生素类药物瑞他莫林的方法
CN114096231A (zh) * 2019-08-01 2022-02-25 联合利华知识产权控股有限公司 一种抗头皮屑组合物

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE789629A (fr) * 1971-10-05 1973-04-03 Sandoz Sa Nouveaux derives de la pleuromutiline, leur preparation et leurapplication en therapeutique
US4130709A (en) 1977-12-08 1978-12-19 Eli Lilly And Company Pleuromutilin glycoside derivatives
JPS54160358A (en) * 1978-06-06 1979-12-19 Sandoz Ag Improvement for organic compound
CY1353A (en) * 1979-01-12 1987-04-24 Sandoz Ag New pleuromutilin derivatives, their production and use
JPH0613528B2 (ja) * 1985-08-20 1994-02-23 塩野義製薬株式会社 セフエム化合物のメトキシ化法
US5376645A (en) 1990-01-23 1994-12-27 University Of Kansas Derivatives of cyclodextrins exhibiting enhanced aqueous solubility and the use thereof
KR0166088B1 (ko) 1990-01-23 1999-01-15 . 수용해도가 증가된 시클로덱스트린 유도체 및 이의 용도
AT397654B (de) * 1992-05-04 1994-06-27 Biochemie Gmbh Neue pleuromutilinderivate, ihre verwendung und verfahren zu ihrer herstellung
GB9711643D0 (en) 1997-06-05 1997-07-30 Janssen Pharmaceutica Nv Glass thermoplastic systems
GB9713730D0 (en) * 1997-06-30 1997-09-03 Ciba Geigy Ag Organic compounds
UY25225A1 (es) * 1997-10-29 2000-12-29 Smithkline Beecham Plc Derivados de pleuromutilina utiles como agentes antimicrobianos
AU769319B2 (en) * 1998-12-22 2004-01-22 F. Hoffmann-La Roche Ag Sulfonamide hydroxamates
GB9918037D0 (en) 1999-07-30 1999-09-29 Biochemie Gmbh Organic compounds
TWI260220B (en) * 1999-11-22 2006-08-21 Novartis Ag A pharmaceutical composition for the transdermal treatment of bacterial infections in animals
SI1294358T1 (en) 2000-06-28 2004-12-31 Smithkline Beecham Plc Wet milling process
JP2005501800A (ja) * 2001-02-02 2005-01-20 三菱ウェルファーマ株式会社 ジヒドロピラゾロピリジン化合物およびその医薬用途
GB0207495D0 (en) 2002-03-28 2002-05-08 Biochemie Gmbh Organic compounds
MXPA05000984A (es) 2002-07-24 2005-09-12 Sandoz Ag Derivados de pleuromutilina como antimicrobianos.
ES2335284T3 (es) 2003-09-03 2010-03-24 Glaxo Group Limited Nuevo procedimiento para preparar derivados de pleuromutilina.
GB0504314D0 (en) 2005-03-02 2005-04-06 Glaxo Group Ltd Novel polymorph
WO2006104667A2 (en) 2005-03-10 2006-10-05 Smithkline Beecham Corporation Novel method

Also Published As

Publication number Publication date
EP1663220A1 (de) 2006-06-07
US20060276503A1 (en) 2006-12-07
JP5719331B2 (ja) 2015-05-20
ES2335284T3 (es) 2010-03-24
JP2012020998A (ja) 2012-02-02
US7875630B2 (en) 2011-01-25
DE602004024417D1 (de) 2010-01-14
JP2012236850A (ja) 2012-12-06
JP5685156B2 (ja) 2015-03-18
JP2015013882A (ja) 2015-01-22
US20110144151A1 (en) 2011-06-16
JP2007504231A (ja) 2007-03-01
JP5460947B2 (ja) 2014-04-02
WO2005023257A1 (en) 2005-03-17
EP2181995A3 (de) 2010-06-16
EP1663220B1 (de) 2009-12-02
EP1663220A4 (de) 2007-04-18
EP2181995A2 (de) 2010-05-05
US8207191B2 (en) 2012-06-26

Similar Documents

Publication Publication Date Title
ATE450535T1 (de) Neues verfahren zur herstellung von pleuromutilinderivaten
AR029175A1 (es) Derivados 2-amino-fenilpurina, un proceso para su preparacion, composicion farmaceutica que los comprende, y el uso de los mismos para la preparacion de un medicamento
ATE361077T1 (de) Indanylderivate zur behandlung von atemwegserkrankungen
UY26139A1 (es) Composiciones de medicamentos a base de compuestos anticolinérgicamente activos y beta- miméticos
GEP20043269B (en) Purine Derivatives, Method for Their Production and Composition Containing the Same
GEP20074208B (en) Substituted amides active at the cannabinoid-1 receptor
WO2004037807A3 (en) Medicinal arylethanolamine compounds
ATE268179T1 (de) Verwendung von substituierten imidazo (1,2- a)pyridin-, -pyrimidin- und -pyrazin-3-yl-amin- derivaten zur herstellung von medikamenten zur nos-inhibierung
NO2010023I1 (no) Vernakalant eller et solvat eller farmasøytisk akseptabelt salt derav, herunder inkludert vernakalanthydroklorid
GEP20043324B (en) Purine Derivatives
UY27300A1 (es) Nuevos derivados de quinolina
AU2003222841A1 (en) Phenethanolamine derivatives
AR029174A1 (es) Derivados de espirooxindol, proceso para su preparacion, formulacion farmaceutica, y utilizacion de los derivados en la manufactura de medicamentos
BRPI0412526A (pt) composto, uso de um composto, composição farmacêutica, formulação em aerossol farmacêutica, e, método para o tratamento de um paciente humano ou animal com uma condição anti-inflamatória e/ou alérgica
AR020001A1 (es) COMPUESTOS ACTIVADORES DE hPPARGAMMA Y hPPARALFA, COMPOSICIONES FARMACEUTICAS QUE LOS COMPRENDEN, METODO PARA EL TRATAMIENTO Y/O PREVENCION DE UNAENFERMEDAD MEDIADA POR LOS MISMOS, Y SU USO PARA LA ELABORACION DE UN MEDICAMENTO
UY26372A1 (es) &#34;imidazo-3-il-aminas bicíclicas procedimiento para su preparación y medicamentos que las contienen &#34;
BR0211228A (pt) Composto, composição farmacêutica e seus usos
BR0210122A (pt) Composto ou um sal farmaceuticamente aceitável do mesmo, método para o tratamento ou prevenção de uma doença, uso do composto ou de seu sal, e, método para preparar o mesmo
CY1114803T1 (el) Παραγωγα πυριμιδινο σουλφοναμιδιου ως ρυθμιστες υποδοχεων χημειοκινης
ES2077199T3 (es) Nuevas piperacinas 1,4-disustituidas, su procedimiento de preparacion y composiciones farmaceuticas que las contienen.
GB0109122D0 (en) Novel compounds
WO2002088100A3 (de) Deuterierte 3-piperidinopropiophenone sowie diese verbindungen enthaltende arzneimittel
ES2163425T3 (es) Uso de raloxifeno y de sus analogos para la fabricacion de un medicamento para el tratamiento de la ateroesclerosis y la enfermedad cardiaca isquemica.
MXPA03000439A (es) Nueva forma de (r)-n-(5-metil -8-(4-metilpiperazin -1-il) -1,2,3,4-tetrahidro-2-naftil) -4-morfolinobenzamida.
HUP9902135A2 (hu) (+)-alfa-(2,3-Dimetoxi-fenil)-1-[2-(4-fluor-fenil)-etil]-4-piperidin-metanol alkalmazása depresszív és bipoláris rendellenességek kezelésére alkalmas gyógyszerkészítmény előállítására

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties